249 related articles for article (PubMed ID: 12598313)
21. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma.
Hisaoka M; Ishida T; Imamura T; Hashimoto H
Genes Chromosomes Cancer; 2004 Aug; 40(4):325-8. PubMed ID: 15188455
[TBL] [Abstract][Full Text] [Related]
22. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics.
Hisaoka M; Hashimoto H
Pathol Int; 2005 Aug; 55(8):453-63. PubMed ID: 15998372
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry.
Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F
Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
25. Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma.
Hirabayashi Y; Ishida T; Yoshida MA; Kojima T; Ebihara Y; Machinami R; Ikeuchi T
Cancer Genet Cytogenet; 1995 May; 81(1):33-7. PubMed ID: 7773957
[TBL] [Abstract][Full Text] [Related]
26. The TFG-TEC oncoprotein induces transcriptional activation of the human β-enolase gene via chromatin modification of the promoter region.
Kim AY; Lim B; Choi J; Kim J
Mol Carcinog; 2016 Oct; 55(10):1411-23. PubMed ID: 26310886
[TBL] [Abstract][Full Text] [Related]
27. Extraskeletal and Skeletal Myxoid Chondrosarcoma: A Multiparameter Analysis of Three Cases Including Cytogenetic Analysis and Fluorescence In Situ Hybridization.
Rao UN; Surti U; Hoffner L; Howard T; Leger W; Contis L; Yaw K
Mol Diagn; 1996 Jun; 1(2):99-107. PubMed ID: 10330205
[TBL] [Abstract][Full Text] [Related]
28. Poorly differentiated extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q11) translocation presenting initially as a solid variant devoid of myxoid areas.
Reid R; de Silva MV; Paterson L
Int J Surg Pathol; 2003 Apr; 11(2):137-41. PubMed ID: 12754636
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
31. The TFG-TEC fusion gene created by the t(3;9) translocation in human extraskeletal myxoid chondrosarcomas encodes a more potent transcriptional activator than TEC.
Lim B; Jun HJ; Kim AY; Kim S; Choi J; Kim J
Carcinogenesis; 2012 Aug; 33(8):1450-8. PubMed ID: 22581839
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation.
Labelle Y; Zucman J; Stenman G; Kindblom LG; Knight J; Turc-Carel C; Dockhorn-Dworniczak B; Mandahl N; Desmaze C; Peter M
Hum Mol Genet; 1995 Dec; 4(12):2219-26. PubMed ID: 8634690
[TBL] [Abstract][Full Text] [Related]
33. Extraskeletal myxoid chondrosarcoma of the jugular foramen.
Cummings TJ; Bridge JA; Fukushima T
Clin Neuropathol; 2004; 23(5):232-7. PubMed ID: 15581026
[TBL] [Abstract][Full Text] [Related]
34. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
[TBL] [Abstract][Full Text] [Related]
35. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas.
Cerretini R; Noriega MF; Narbaitz M; Slavutsky I
Eur J Haematol; 2006 Apr; 76(4):284-93. PubMed ID: 16519699
[TBL] [Abstract][Full Text] [Related]
36. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
37. Localization of TEC to 9q22.3-q31 by fluorescence in situ hybridization.
Kleinfinger P; Labelle Y; Melot T; Thomas G; Delattre O; Aurias A
Ann Genet; 1996; 39(4):233-5. PubMed ID: 9037350
[TBL] [Abstract][Full Text] [Related]
38. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
39. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.
Folpe AL; Agoff SN; Willis J; Weiss SW
Am J Surg Pathol; 1999 Sep; 23(9):1059-67. PubMed ID: 10478665
[TBL] [Abstract][Full Text] [Related]
40. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22.
Hinrichs SH; Jaramillo MA; Gumerlock PH; Gardner MB; Lewis JP; Freeman AE
Cancer Genet Cytogenet; 1985 Jan; 14(3-4):219-26. PubMed ID: 3967207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
